JDBRX
Price
$50.37
Change
+$0.16 (+0.32%)
Updated
Oct 17 closing price
Net Assets
28.02B
RLBEX
Price
$38.94
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.62B
Interact to see
Advertisement

JDBRX vs RLBEX

Header iconJDBRX vs RLBEX Comparison
Open Charts JDBRX vs RLBEXBanner chart's image
Janus Henderson Balanced R
Price$50.37
Change+$0.16 (+0.32%)
VolumeN/A
Net Assets28.02B
American Funds American Balanced R4
Price$38.94
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.62B
JDBRX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
JDBRX vs. RLBEX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDBRX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 266B vs. JDBRX (28B). RLBEX pays higher dividends than JDBRX: RLBEX (1.74) vs JDBRX (1.17). JDBRX was incepted earlier than RLBEX: JDBRX (16 years) vs RLBEX (23 years). JDBRX (1.31) is less costly to investors than RLBEX (0.59). JDBRX is a more actively managed with annual turnover of: 76.00 vs. RLBEX (44.00). RLBEX has a lower initial minimum investment than JDBRX: RLBEX (250) vs JDBRX (2500). RLBEX annual gain was more profitable for investors over the last year : 8.70 vs. JDBRX (6.79). RLBEX return over 5 years is better than : 42.04 vs. JDBRX (34.60).
JDBRXRLBEXJDBRX / RLBEX
Total Expense Ratio1.310.59222%
Annual Report Gross Expense Ratio1.310.59222%
Fund Existence16 years23 years-
Gain YTD12.42414.63185%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets28B266B11%
Annual Yield % from dividends1.171.7467%
Returns for 1 year6.798.7078%
Returns for 3 years44.6750.5288%
Returns for 5 years34.6042.0482%
Returns for 10 years88.6077.69114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
DHT12.110.23
+1.94%
DHT Holdings
PTLO5.900.02
+0.34%
Portillo's
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma